Label: HYDROCORTISONE AND ACETIC ACID solution

  • NDC Code(s): 0713-0849-09
  • Packager: Cosette Pharmaceuticals, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated February 2, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing benzethonium chloride (0.02%), citric acid (0.05%), propylene glycol diacetate (3%) and sodium acetate (0.0025%). The empirical formulas for acetic acid and hydrocortisone are CH 3COOH, and C 21H 30O 5, with a molecular weight of 60.05 and 362.46, respectively.
    The structural formulas are:

    Structure

    Hydrocortisone and Acetic Acid is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

  • CLINICAL PHARMACOLOGY

    Acetic acid is antibacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

  • INDICATIONS AND USAGE

    For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

  • CONTRAINDICATIONS

    Hypersensitivity to Hydrocortisone and Acetic Acid or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

  • WARNINGS

    Discontinue promptly if sensitization or irritation occurs.

  • PRECAUTIONS

    Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

    Pediatric Use

    Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

  • ADVERSE REACTIONS

    Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

    To report SUSPECTED ADVERSE REACTIONS, contact Cosette Pharmaceuticals, Inc. at 1-800-922-1038 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

  • DOSAGE AND ADMINISTRATION

    Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

  • HOW SUPPLIED

    Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles (NDC 0713-0849-09).

  • STORAGE

    Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
    Keep container tightly closed.

    Rx only

    Distributed by:
    Cosette Pharmaceuticals, Inc.
    South Plainfield, NJ 07080

    Rev. 12/2023
    8-0849CPLNC1
    VC7758

  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

    NDC 0713- 0849-09

    Rx only

    Hydrocortisone and Acetic Acid Otic Solution, USP

    10 mL

    Cosette Pharmaceuticals, Inc.

    Carton

    NDC 0713- 0849-09

    Rx only

    Hydrocortisone and Acetic Acid Otic Solution, USP

    10 mL

    Cosette Pharmaceuticals, Inc.

    Bottle

  • INGREDIENTS AND APPEARANCE
    HYDROCORTISONE AND ACETIC ACID 
    hydrocortisone and acetic acid solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0713-0849
    Route of AdministrationAURICULAR (OTIC)
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ACETIC ACID (UNII: Q40Q9N063P) (ACETIC ACID - UNII:Q40Q9N063P) ACETIC ACID20 mg  in 1 mL
    HYDROCORTISONE (UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ) HYDROCORTISONE10 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    BENZETHONIUM CHLORIDE (UNII: PH41D05744)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PROPYLENE GLYCOL DIACETATE (UNII: 5Z492UNF9O)  
    SODIUM ACETATE (UNII: 4550K0SC9B)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0713-0849-091 in 1 CARTON02/01/2024
    110 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA04060902/01/2024
    Labeler - Cosette Pharmaceuticals, Inc. (116918230)
    Registrant - Cosette Pharmaceuticals, Inc. (116918230)
    Establishment
    NameAddressID/FEIBusiness Operations
    Cosette Pharmaceuticals NC Laboratories, LLC079419931analysis(0713-0849) , label(0713-0849) , manufacture(0713-0849) , pack(0713-0849)